Department of Respiratory Medicine, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, UK
National Heart and Lung Institute, Imperial College London, London, UK.
Thorax. 2024 Aug 19;79(9):870-877. doi: 10.1136/thorax-2023-220647.
The role of Xpert Ultra in bronchoalveolar lavage (BAL) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) samples for pulmonary and mediastinal lymph node tuberculosis (TB) remains unclear.
This was a retrospective observational service evaluation at a tertiary TB centre in a low-incidence setting. The diagnostic indices of Xpert Ultra, smear and culture (with cytology for EBUS-TBNA samples) were compared with culture positivity or a composite reference standard of clinical TB diagnosis. Trace readouts, a new category of results for Xpert Ultra indicating low bacillary load, were analysed in two ways as a true positive or true negative result. 282 BAL and 139 EBUS-TBNA samples were included in the analysis.
BAL: sensitivity with 95% CI against culture-confirmed pulmonary TB from BAL samples for Xpert Ultra (trace as positive) was 0.91 (0.82 to 0.98), Xpert Ultra (trace as negative) was 0.76 (0.69 to 0.83), smear was 0.38 (p=0.0009) and culture was 1.00 (0.91 to 1.00). Specificities for all the tests were ≥0.99 (0.98 to 1.00). The addition of smear to Xpert Ultra did not improve the diagnostic accuracy.EBUS-TBNA: sensitivity against culture-confirmed TB from EBUS-TBNA samples for Xpert Ultra (trace as positive) was 0.71 (0.63 to 0.78), Xpert Ultra (trace as negative) was 0.59 (0.54 to 0.63), smear was 0.12 (p=0.002), culture was 1.00 (0.89 to 1.00), cytology was 0.87 (0.76 to 0.98) and rapid on-site evaluation of cytology (ROSE) was 0.92 (0.78 to 1.00). Specificities were 0.99 (0.97 to 1.00), 0.99 (0.97 to 1.00), 1.00 (0.98 to 1.00), 1.00 (0.98 to 1.00), 0.67 (0.67 to 0.68) and 0.42, respectively.
Xpert Ultra had a significantly higher sensitivity compared with smear in both BAL and EBUS-TBNA samples. Xpert Ultra had a lower sensitivity compared with culture but comparable specificity with results being available within <24 hours. Trace readings in our low-incidence setting were associated with culture positivity in all BAL samples.
Xpert Ultra 在支气管肺泡灌洗(BAL)和支气管内超声引导经支气管针吸活检(EBUS-TBNA)标本中对肺和纵隔淋巴结结核(TB)的作用仍不清楚。
这是在低发病率环境中的三级 TB 中心进行的回顾性观察性服务评估。比较了 Xpert Ultra 的诊断指标、涂片和培养(EBUS-TBNA 标本进行细胞学检查)与培养阳性或临床 TB 诊断的综合参考标准。Trace 读数是 Xpert Ultra 的一个新类别结果,表明细菌载量低,以两种方式分析为真阳性或真阴性结果。共纳入 282 例 BAL 和 139 例 EBUS-TBNA 样本进行分析。
BAL:Xpert Ultra(Trace 为阳性)与 BAL 样本培养证实的肺结核相比,95%CI 的敏感性为 0.91(0.82 至 0.98),Xpert Ultra(Trace 为阴性)为 0.76(0.69 至 0.83),涂片为 0.38(p=0.0009),培养为 1.00(0.91 至 1.00)。所有试验的特异性均≥0.99(0.98 至 1.00)。在 Xpert Ultra 中添加涂片并不能提高诊断准确性。
EBUS-TBNA:Xpert Ultra(Trace 为阳性)与 EBUS-TBNA 样本培养证实的结核相比,敏感性为 0.71(0.63 至 0.78),Xpert Ultra(Trace 为阴性)为 0.59(0.54 至 0.63),涂片为 0.12(p=0.002),培养为 1.00(0.89 至 1.00),细胞学为 0.87(0.76 至 0.98),快速现场细胞学评估(ROSE)为 0.92(0.78 至 1.00)。特异性分别为 0.99(0.97 至 1.00)、0.99(0.97 至 1.00)、1.00(0.98 至 1.00)、1.00(0.98 至 1.00)、0.67(0.67 至 0.68)和 0.42。
与涂片相比,Xpert Ultra 在 BAL 和 EBUS-TBNA 样本中的敏感性均显著更高。Xpert Ultra 的敏感性低于培养,但特异性相当,结果可在 24 小时内获得。在我们的低发病率环境中,Trace 读数与所有 BAL 样本的培养阳性相关。